Honz Pharmaceutical Co., Ltd. (SHE:300086)

Honz Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	17.95	113.53	145.09	270.11	258.99	259.04
Cash & Short-Term Investments	17.95	113.53	145.09	270.11	258.99	259.04
Cash Growth	-85.48%	-21.75%	-46.28%	4.29%	-0.02%	38.52%
Accounts Receivable	50	69.06	139.63	73.14	153.16	158.76
Other Receivables	28.27	25.92	39.26	52.59	66.3	21.53
Receivables	78.27	94.99	178.89	125.73	219.45	180.29
Inventory	166.89	187.33	236.43	170.4	197.87	209.95
Prepaid Expenses	-	0.38	0.43	-	-	-
Other Current Assets	47.45	46.85	48.51	104.22	43.59	59.7
Total Current Assets	310.56	443.07	609.35	670.46	719.9	708.98
Property, Plant & Equipment	722.55	1,022	987.29	950.53	989.88	904.23
Long-Term Investments	4.97	4.97	5.3	5.95	10.98	19.6
Goodwill	13.5	13.5	20.05	18.89	18.89	308.65
Other Intangible Assets	101.85	139.86	160.33	167.55	202.68	163.73
Long-Term Deferred Tax Assets	64.22	50.65	42.3	47.9	25.94	31.03
Long-Term Deferred Charges	81.92	77.87	81.02	75.21	72.86	72.73
Other Long-Term Assets	579.21	223.65	259.98	351.98	417.66	404.72
Total Assets	1,879	1,976	2,166	2,288	2,459	2,614
Accounts Payable	52.82	66.26	78.02	57.4	112.33	110.36
Accrued Expenses	7.6	39.74	44.29	43.8	30.47	30.68
Short-Term Debt	166.57	171.08	139.89	133.22	148.5	297.58
Current Portion of Long-Term Debt	67.45	110.51	36.77	107.05	100.78	-
Current Portion of Leases	-	0.46	-	-	-	-
Current Income Taxes Payable	13.68	3.03	16.27	3.77	4.16	9.54
Current Unearned Revenue	16.73	42.21	10.79	95.66	26.1	23.85
Other Current Liabilities	136.9	62.39	54.56	63.61	62.59	108.77
Total Current Liabilities	461.75	495.68	380.59	504.51	484.92	580.78
Long-Term Debt	233.07	210	324.98	342.85	343.52	324.5
Long-Term Leases	19.19	18.65	-	-	-	-
Long-Term Unearned Revenue	54.64	51.63	48.18	51	35.61	36.72
Long-Term Deferred Tax Liabilities	36.53	34.58	33.86	34.6	41.09	41.83
Other Long-Term Liabilities	-	-	-	-	-	28.1
Total Liabilities	805.18	810.53	787.6	932.96	905.14	1,012
Common Stock	455.12	455.12	450	450	450	450
Additional Paid-In Capital	842.99	842.99	836.49	818.96	818.96	819.94
Retained Earnings	-306.54	-209.93	6.28	-5.25	182.34	180.35
Comprehensive Income & Other	58.13	51.73	51.98	52.47	52.65	52.17
Total Common Equity	1,050	1,140	1,345	1,316	1,504	1,502
Minority Interest	23.88	25.4	33.26	39.33	49.69	99.29
Shareholders' Equity	1,074	1,165	1,378	1,356	1,554	1,602
Total Liabilities & Equity	1,879	1,976	2,166	2,288	2,459	2,614
Total Debt	486.28	510.7	501.64	583.12	592.8	622.07
Net Cash (Debt)	-468.32	-397.17	-356.55	-313.01	-333.8	-363.03
Net Cash Per Share	-1.03	-0.87	-0.79	-0.70	-0.74	-0.81
Filing Date Shares Outstanding	455.12	455.12	450	450	450	450
Total Common Shares Outstanding	455.12	455.12	450	450	450	450
Working Capital	-151.19	-52.61	228.76	165.95	234.98	128.2
Book Value Per Share	2.31	2.50	2.99	2.92	3.34	3.34
Tangible Book Value	934.36	986.56	1,164	1,130	1,282	1,030
Tangible Book Value Per Share	2.05	2.17	2.59	2.51	2.85	2.29
Buildings	-	1,054	872.16	860.84	362.09	342.42
Machinery	-	398.28	383.47	381.58	289.25	340.83
Construction In Progress	-	12.03	145.62	59.59	659.28	572.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.